Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and tolerability of methadone + naloxone in opioid substitution treatment
2010-021814-43Phase 2Terminated
- Sponsor
- Ulrich Tacke
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methadone + naloxone in opioid use disorder (OUD), sponsored by Ulrich Tacke. Primary endpoints: Withdrawal symptoms (COWS) and Withdrawal symptoms (SOWS). Started Aug 2010; status: terminated.
02
Drugs
methadone + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2010-021814-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021814-43.